• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中去甲肾上腺素能系统的神经病理学和生化观察

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

作者信息

Perry E K, Tomlinson B E, Blessed G, Perry R H, Cross A J, Crow T J

出版信息

J Neurol Sci. 1981 Aug;51(2):279-87. doi: 10.1016/0022-510x(81)90106-4.

DOI:10.1016/0022-510x(81)90106-4
PMID:7276979
Abstract

Abnormalities of the noradrenergic system in Alzheimer's disease have been investigated by comparing quantitative histological and biochemical components of this transmitter system (locus coeruleus neuron counts and cortical dopamine beta-hydroxylase (DBH) activity, respectively) in a series of demented and non-demented cases. Cortical activities of the noradrenergic enzyme, DBH, did not correlate significantly with the number of locus coeruleus neurons, a finding which contrasts with the previous observations in animal brains of reductions in cortical DBH following locus coeruleus lesions. The extent of Alzheimer-type abnormalities, assessed from either morphological measures (mean plaque counts) or clinical measures (Mental Test Scores) of severity, was not significantly related to the cortical activity of DBH in the present series of cases, although non-significant trends were apparent. In contrast the activity of the cholinergic enzyme choline acetyltransferase did, as previously reported, correlate significantly with the extent of Alzheimer-type abnormalities, suggesting that abnormalities of the cholinergic system are more closely associated with specific aspects of the Alzheimer disease process than those of the noradrenergic system.

摘要

通过比较一系列痴呆和非痴呆病例中该递质系统的定量组织学和生化成分(分别为蓝斑神经元计数和皮质多巴胺β-羟化酶(DBH)活性),对阿尔茨海默病中去甲肾上腺素能系统的异常进行了研究。去甲肾上腺素能酶DBH的皮质活性与蓝斑神经元数量无显著相关性,这一发现与之前在动物脑中观察到的蓝斑损伤后皮质DBH降低的情况形成对比。在本系列病例中,从形态学指标(平均斑块计数)或临床指标(精神测试评分)评估的阿尔茨海默病型异常程度与DBH的皮质活性无显著相关性,尽管有不显著的趋势。相比之下,正如之前报道的,胆碱能酶胆碱乙酰转移酶的活性与阿尔茨海默病型异常程度显著相关,这表明胆碱能系统的异常比去甲肾上腺素能系统的异常更紧密地与阿尔茨海默病进程的特定方面相关。

相似文献

1
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.阿尔茨海默病中去甲肾上腺素能系统的神经病理学和生化观察
J Neurol Sci. 1981 Aug;51(2):279-87. doi: 10.1016/0022-510x(81)90106-4.
2
Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type.阿尔茨海默病型老年痴呆症中蓝斑色素性多巴胺-β-羟化酶阳性细胞的丧失。
Neurosci Lett. 1983 Aug 19;39(1):95-100. doi: 10.1016/0304-3940(83)90171-4.
3
Noradrenergic and cholinergic systems in senile dementia of Alzheimer type.阿尔茨海默型老年痴呆症中的去甲肾上腺素能和胆碱能系统。
Lancet. 1981 Jul 18;2(8238):149. doi: 10.1016/s0140-6736(81)90327-5.
4
Development and distribution of noradrenergic and cholinergic neurons and their trophic phenotypes in the avian ceruleus complex and midbrain tegmentum.去甲肾上腺素能和胆碱能神经元在鸟类蓝斑复合体和中脑被盖中的发育、分布及其营养表型
J Comp Neurol. 1992 Jun 22;320(4):479-500. doi: 10.1002/cne.903200406.
5
The toxicity of tumor necrosis factor-alpha upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for Alzheimer's disease.肿瘤坏死因子-α 对基底核内胆碱能神经元的毒性作用以及去甲肾上腺素在炎症调节中的作用:对阿尔茨海默病的启示
Neuroscience. 2003;121(3):719-29. doi: 10.1016/s0306-4522(03)00545-1.
6
Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.帕金森病和阿尔茨海默病中蓝斑核神经元丧失对中枢去甲肾上腺素能神经系统的不同反应。
Brain Res. 2011 Feb 10;1373:240-52. doi: 10.1016/j.brainres.2010.12.015. Epub 2010 Dec 11.
7
Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.与衰老及阿尔茨海默病型变化相关的人类颞叶神经化学活动。
Neurobiol Aging. 1981 Winter;2(4):251-6. doi: 10.1016/0197-4580(81)90032-4.
8
Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease.蓝斑核中的神经元变性与阿尔茨海默病的皮质相关性
Alzheimer Dis Assoc Disord. 1987;1(4):256-62. doi: 10.1097/00002093-198701040-00005.
9
Noradrenergic changes, aggressive behavior, and cognition in patients with dementia.痴呆患者的去甲肾上腺素能变化、攻击行为与认知
Biol Psychiatry. 2002 Mar 1;51(5):407-16. doi: 10.1016/s0006-3223(01)01235-5.
10
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.帕金森病认知障碍的胆碱能相关性:与阿尔茨海默病的比较。
J Neurol Neurosurg Psychiatry. 1985 May;48(5):413-21. doi: 10.1136/jnnp.48.5.413.

引用本文的文献

1
GABAergic dysfunction in postmortem dorsolateral prefrontal cortex: implications for cognitive deficits in schizophrenia and affective disorders.死后背外侧前额叶皮质中的γ-氨基丁酸能功能障碍:对精神分裂症和情感障碍认知缺陷的影响
Front Cell Neurosci. 2024 Sep 24;18:1440834. doi: 10.3389/fncel.2024.1440834. eCollection 2024.
2
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.阿尔茨海默病是人类大脑自然老化的固有组成部分:综合视角。
Free Neuropathol. 2022 Jul 8;3:17. doi: 10.17879/freeneuropathology-2022-3806. eCollection 2022 Jan.
3
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.
阿尔茨海默病:去甲肾上腺素参与的不断发展的认识和电疗疗法的广阔前景。
Clin Transl Med. 2021 Apr;11(4):e397. doi: 10.1002/ctm2.397.
4
Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.脑脊液阿尔茨海默病生物标志物与 COMT、DBH 和 MAOB 单核苷酸多态性的关系。
J Alzheimers Dis. 2020;73(1):135-145. doi: 10.3233/JAD-190991.
5
Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research.重新审视阿尔茨海默病中的胆碱能假说:转化和临床研究的新证据。
J Prev Alzheimers Dis. 2019;6(1):2-15. doi: 10.14283/jpad.2018.43.
6
Early neurone loss in Alzheimer's disease: cortical or subcortical?阿尔茨海默病中的早期神经元丧失:皮质还是皮质下?
Acta Neuropathol Commun. 2015 Feb 10;3:10. doi: 10.1186/s40478-015-0187-1.
7
Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.阿尔茨海默病患者血浆多巴胺β羟化酶活性的基因型独立降低。
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:94-9. doi: 10.1016/j.pnpbp.2013.02.002. Epub 2013 Feb 13.
8
Opioid system and Alzheimer's disease.阿片系统与阿尔茨海默病。
Neuromolecular Med. 2012 Jun;14(2):91-111. doi: 10.1007/s12017-012-8180-3. Epub 2012 Apr 22.
9
The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.多巴胺 β-羟化酶-1021C/T 多态性与 Epistasis 项目中阿尔茨海默病的风险相关。
BMC Med Genet. 2010 Nov 11;11:162. doi: 10.1186/1471-2350-11-162.
10
The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.阿尔茨海默病的认知神经药理学:聚焦胆碱能系统。
Neurochem Res. 1998 May;23(5):787-94. doi: 10.1023/a:1022419712453.